{
    "organizations": [],
    "uuid": "a2e26e155da8fb123cdfdfd8cc455df2eec51937",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-xbrane-biopharma-q4-ebitda-loss-wi/brief-xbrane-biopharma-q4-ebitda-loss-widens-to-sek-18-0-mln-idUSFWN1QI05G",
    "ord_in_thread": 0,
    "title": "BRIEF-Xbrane Biopharma Q4 EBITDA Loss Widens To SEK 18.0 Mln",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 28 (Reuters) - XBRANE BIOPHARMA AB:\n* Q4 EBITDA LOSS SEK 18.0‍​ MILLION VERSUS LOSS SEK 8.1 MILLION YEAR AGO\n* ‍PROPOSE NO DIVIDEND FOR FISCAL YEAR 2017​ Source text for Eikon: Further company coverage: (Gdynia Newsroom)\n ",
    "published": "2018-02-28T15:45:00.000+02:00",
    "crawled": "2018-03-01T21:01:46.006+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "xbrane",
        "biopharma",
        "ab",
        "q4",
        "ebitda",
        "loss",
        "sek",
        "million",
        "versus",
        "loss",
        "sek",
        "million",
        "year",
        "ago",
        "dividend",
        "fiscal",
        "year",
        "source",
        "text",
        "eikon",
        "company",
        "coverage",
        "gdynia",
        "newsroom"
    ]
}